Ledyard National Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$988K Sell
17,142
-107
-0.6% -$6.14K 0.08% 127
2026
Q1
$1.05M Sell
17,249
-47
-0.3% -$2.74K 0.09% 116
2025
Q4
$933K Sell
17,296
-351
-2% -$16.9K 0.08% 119
2025
Q3
$796K Sell
17,647
-1,009
-5% -$47.1K 0.07% 123
2025
Q2
$864K Sell
18,656
-4,396
-19% -$216K 0.08% 121
2025
Q1
$1.41M Sell
23,052
-618
-3% -$36K 0.14% 95
2024
Q4
$1.34M Sell
23,670
-1,548
-6% -$86.5K 0.13% 94
2024
Q3
$1.3M Sell
25,218
-585
-2% -$27.4K 0.12% 100
2024
Q2
$1.07M Sell
25,803
-2,345
-8% -$105K 0.1% 106
2024
Q1
$1.53M Sell
28,148
-3,035
-10% -$155K 0.15% 89
2023
Q4
$1.6M Buy
31,183
+393
+1% +$20.6K 0.16% 86
2023
Q3
$1.79M Sell
30,790
-283
-0.9% -$17.3K 0.2% 78
2023
Q2
$1.99M Sell
31,073
-475
-2% -$31.9K 0.22% 79
2023
Q1
$2.19M Sell
31,548
-379
-1% -$26.7K 0.25% 79
2022
Q4
$2.3M Sell
31,927
-168
-0.5% -$12.7K 0.27% 77
2022
Q3
$2.28M Sell
32,095
-709
-2% -$51.4K 0.3% 77
2022
Q2
$2.53M Sell
32,804
-1,245
-4% -$94.8K 0.31% 80
2022
Q1
$2.49M Sell
34,049
-80
-0.2% -$5.37K 0.25% 86
2021
Q4
$2.13M Sell
34,129
-3,771
-10% -$221K 0.2% 89
2021
Q3
$2.24M Buy
37,900
+458
+1% +$30.2K 0.23% 86
2021
Q2
$2.5M Buy
37,442
+210
+0.6% +$13.7K 0.26% 86
2021
Q1
$2.35M Buy
37,232
+910
+3% +$56.6K 0.25% 86
2020
Q4
$2.25M Buy
36,322
+1,065
+3% +$65.5K 0.26% 88
2020
Q3
$2.13M Sell
35,257
-1,410
-4% -$84.9K 0.27% 83
2020
Q2
$2.16M Buy
36,667
+772
+2% +$46.2K 0.29% 83
2020
Q1
$2M Buy
35,895
+9,540
+36% +$583K 0.31% 90
2019
Q4
$1.69M Buy
26,355
+2,069
+9% +$118K 0.21% 114
2019
Q3
$1.23M Sell
24,286
-399
-2% -$18.8K 0.16% 119
2019
Q2
$1.12M Sell
24,685
-581
-2% -$27.1K 0.15% 126
2019
Q1
$1.21M Sell
25,266
-69
-0.3% -$3.44K 0.16% 123
2018
Q4
$1.32M Sell
25,335
-1,909
-7% -$103K 0.17% 124
2018
Q3
$1.69M Sell
27,244
-231
-0.8% -$13.7K 0.19% 121
2018
Q2
$1.52M Sell
27,475
-779
-3% -$42.1K 0.18% 125
2018
Q1
$1.79M Sell
28,254
-744
-3% -$47.9K 0.22% 118
2017
Q4
$1.78M Sell
28,998
-1,036
-3% -$64.8K 0.22% 116
2017
Q3
$1.91M Buy
30,034
+1,043
+4% +$60.9K 0.25% 104
2017
Q2
$1.62M Buy
28,991
+1,743
+6% +$94.8K 0.23% 104
2017
Q1
$1.48M Buy
27,248
+5,533
+25% +$303K 0.22% 105
2016
Q4
$1.27M Sell
21,715
-1,100
-5% -$60.1K 0.23% 99
2016
Q3
$1.23M Buy
22,815
+1,209
+6% +$77.7K 0.22% 101
2016
Q2
$1.59M Sell
21,606
-194
-0.9% -$13.7K 0.29% 92
2016
Q1
$1.39M Sell
21,800
-35
-0.2% -$2.21K 0.25% 100
2015
Q4
$1.5M Sell
21,835
-100
-0.5% -$6.61K 0.27% 91
2015
Q3
$1.3M Sell
21,935
-158
-0.7% -$10K 0.25% 93
2015
Q2
$1.47M Sell
22,093
-435
-2% -$28.7K 0.26% 92
2015
Q1
$1.45M Sell
22,528
-200
-0.9% -$12.5K 0.26% 94
2014
Q4
$1.34M Sell
22,728
-120
-0.5% -$6.77K 0.25% 89
2014
Q3
$1.17M Sell
22,848
-1,075
-4% -$53.7K 0.22% 90
2014
Q2
$1.16M Sell
23,923
-342
-1% -$16.9K 0.19% 88
2014
Q1
$1.26M Buy
24,265
+136
+0.6% +$7.24K 0.21% 89
2013
Q4
$1.28M Sell
24,129
-908
-4% -$46.3K 0.21% 84
2013
Q3
$1.16M Sell
25,037
-306
-1% -$13.4K 0.2% 86
2013
Q2
$1.13M Buy
+25,343
New +$1.1M 0.21% 81

Other funds holding BMY

Ledyard National Bank's BMY Position: Q2 2026 in Review

Ledyard National Bank reduced its Bristol-Myers Squibb (BMY) stake by 0.62% in Q2 2026, selling an estimated $6.14K and leaving 17,142 shares worth $988K. The position accounts for 0.08% of the portfolio, ranked #127.

Ledyard National Bank first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.53M in Q2 2022. 909 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Ledyard National Bank held 17,142 shares of Bristol-Myers Squibb worth $988K as of Q2 2026.
  • Ledyard National Bank sold 107 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.14K.
  • Bristol-Myers Squibb made up 0.08% of Ledyard National Bank's portfolio in Q2 2026, its #127 holding.
  • Ledyard National Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Ledyard National Bank's Bristol-Myers Squibb position peaked at $2.53M in Q2 2022.
  • 909 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Ledyard National Bank's 13F filing for Q2 2026, filed 16 Jul 2026.